3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Chronic Pain
3
Cancer Pain
3
Supratentorial Neoplasms
2
Pain, Postoperative
2
Pain
2
Neoplastic Cells, Circulating
2
Neoplasms
2
Colorectal Neoplasms
2
Agnosia
2
Substance Withdrawal Syndrome
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Nalbuphine Allergy
1
Ileus
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Constipation
1
Breakthrough Pain
1
Brain Neoplasms
1
Age Problem
1
Abdominal Cancer
1
Interventions
Fentanyl
2
Ultracet
1
Morphine
1
Gastrostomy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Breakthrough Pain
×
Morphine
×
Clear all
NCT02869321
2019-05-13
ANTALGIP
Central Hospital, Nancy, France
Phase 4
Completed
20 enrolled